Ziyuan Guo, PhD, and Lu Lu, PhD, standing together in a research lab with laboratory equipment in the background.

METTL3 Inhibitors and FDA-Approved Drugs in a New Fragile X Treatment Strategy Using Organoids

Researchers are testing METTL3 inhibitors and FDA-approved drugs in brain organoids to explore new pathways for treating Fragile X and related disorders.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (39)